AKT1 and hepatocellular carcinoma: In addition, a non-selective adenosine receptor antagonist caffeine, and its analog CGS 15943 has been reported to block the proliferation in HCC and PDAC cell lines by inhibiting the PI3K/Akt pathway (83).